The promise and danger of CRISPR with Neal Baer

When we think about gene processing, the conversation often feels stuck between scientific journals and ethical debates that are too complex for public forums. In this episode I spoke with Neal Baer, a rare voice that bridges both worlds.

Known to many as a award -winning television programs for series such as Is” Law & Order SVUAnd Designated survivorNeal is also a doctor and co-director of the media, medicine and health program at Harvard Medical School. His latest project brings all that experience together in a new collection of essays that investigates the promise and the danger of CRISPR GENE-working technology.

Neal takes us on a journey that starts with his time as a medical resident who treats a young sickle cell patient and leads to a much broader conversation about science, ethics and stories. We discuss how CRISPR is already being used to cure diseases such as sickle cell, and how companies now investigate gene operations that promise permanent reductions in cholesterol. But the real power of this discussion is not only in what CRISPR can do, but in what we still do not fully understand about the long -term impact.

The conversation goes to difficult territory – unfocused mutations, germ line processing, the risk of pathologizing human diversity and the slippery slope of “improvement” where only people with access can benefit. Neal raises critical questions about the social costs of deciding which conditions should be ‘determined’ and who can make that call. We also dive into the lack of political and regulatory supervision, and why a worldwide framework, not just scientific progress, is urgently needed.

This episode offers a powerful memory that the future of CRISPR may not only be left to researchers or startups. It requires broad involvement, from classrooms to policy -making, and inclusive voices that challenge how we define progress.

How should we decide which counts as improvement when the definition of man is at stake?

Useful links

Subscribe to the Tech Talks Daily Podcast